LungLife AI, Inc.(the “Company” or “LungLife”) Notice of Results Investor Briefing LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for the early detection of lung cancer, will announce its unaudited half-year report for the six months ended 30 June 2024 on Thursday 22 August 2024. Investor presentation Paul Pagano, Chief Executive Officer, and […]
LungLife AI, Inc. ("LungLife" or the "Company") Result of Annual General Meeting LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that at its Annual General Meeting, held at earlier today, all 10 resolutions put to members were passed on a poll. Full details of the voting will be available […]
LungLife AI licensure/accreditation information posted here.